Showing results (2451-2460 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|July 8, 2026
Cellular therapy in mantle cell lymphoma: recommendations from the EBMT practice harmonisation and guidelines committeePeter Dreger, Gloria Iacoboni, Stephen Robinson, et al.Bone Marrow Transplantation|July 8, 2026
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMTRyszard Swoboda, Myriam Labopin, Nicolaus Kröger, et al.Bone Marrow Transplantation|June 22, 2026
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020Ben Lerman, Stefan Schönland, Ute Hegenbart, et al.Bone Marrow Transplantation|June 22, 2026
Bendamustine-based lymphodepletion prior to CAR T-cell therapy: a systematic reviewMostafa F Mohammed Saleh, Ahmed Abdrabou, Ahmed Alnughmush, et al.Bone Marrow Transplantation|June 24, 2026
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remissionDaniele Avenoso, Vera Radici, Alessandro Leoni, et al.Bone Marrow Transplantation|July 20, 2026
Allogeneic hematopoietic cell transplantation from haploidentical donors with total body irradiation versus chemo-based regimens for adult AML patients in first complete remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Myriam Labopin, Anna Maria Raiola, et al.Bone Marrow Transplantation|June 9, 2016
Unrelated donor search prognostic score to support early HLA consultation and clinical decisionsK Wadsworth, M Albrecht, R Fonstad, et al.Bone Marrow Transplantation|February 21, 2012
The clinical role of procalcitonin in hematopoietic SCTJ Koya, Y Nannya, M Ichikawa, et al.Bone Marrow Transplantation|July 22, 2026
Conditioning regimen for hematopoietic cell transplant in transfusion dependent thalassemia: Recommendations from the EBMT practice harmonisation and guidelines committeeMohammed Essa, Mattia Algeri, Mohsen Alzahrani, et al.Bone Marrow Transplantation|August 21, 2026
A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group ConsortiumIrwin Walker, Uday Deotare, Mohamed Elemary, et al.Pageof 993